BioPorto CEO announces new strategy
It is a commercial Mr. Turnaround, who now sits at the helm of Danish pharma company, BioPorto. After one day on the job, Peter Mørch Eriksen has already outlined a plan for how the company is to move forward.
by Leonora Beck
Peter Mørch Eriksen has two successful turnarounds on his CV - in the 90s for technology firm Brüel & Kjær, while the diagnostic division in Medtronic came under the care of the commercial expert later on. Now the time has come for BioPorto to make use of his expertise. Peter Mørch Eriksen has already decided on the overall steps for advancement of the distressed diagnostics company.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
